Thalidomide Ok'd For Different Myeloma
The FDA has acclimatized thalidomide -- a biologic acclimatized to could could could could cause acid address defects -- to admonition action afresh diagnosed multiple myelomamultiple myeloma, a cancercancer of the cartilage marrow.
Thalidomide was acclimatized for use in accumulated with accession drug, dexamethasone, for different myeloma. Thalidomide will be ample below the name Thalomid by Celgene Corporation. The biologic will arise in capsules in doses of 50 milligrams, 100 milligrams, and 200 milligrams.
The FDA had advanced acclimatized thalidomide -- with ascetic rules to admonition ahead address defects -- to action debilitating and disfiguring bark sores associated with erythema nodosum leprosum, an anarchic affliction of leprosy.
Those ascetic rules are aswell in address for Thalomid's use in patients with afresh diagnosed different myeloma.
"If thalidomide is taken during pregnancypregnancy, it can could could could could cause acid address defects or afterlife to an abutting baby," states the drug's admonishing label. "Thalidomide should never be acclimated by women who are abounding or who could become abounding while demography the drug," the assuming continues.
Thalidomide aswell carries the blow of potentially alarming clots in the veins, including bottomless attitude occlusion (DVT) and pulmonary embolismpulmonary embolism. DVT are clots in the bottomless veins of the legs. Pulmonary arrangement is a arrangement that attack through the bloodstream to the lungs.